Spyre Therapeutics Inc logo

Spyre Therapeutics Inc

NEW
NAS:SYRE (USA)  
$ 18.03 -0.85 (-4.5%) 07:08 PM EST
At Loss
P/B:
3.00
Enterprise V:
$ 983.30M
Volume:
315.75K
Avg Vol (2M):
638.69K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
315.75K
At Loss
Avg Vol (2M):
638.69K

Business Description

Description
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.85
Interest Coverage No Debt
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.26
Quick Ratio 11.26
Cash Ratio 11.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -212.5
Shareholder Yield % -20.78

Financials (Next Earnings Date:2025-05-09 Est.)

SYRE's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SYRE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Spyre Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.18
Beta 3.91
3-Year Sharpe Ratio 0.32
3-Year Sortino Ratio 0.78
Volatility % 64.71
14-Day RSI 39.63
14-Day ATR ($) 1.620136
20-Day SMA ($) 20.759
12-1 Month Momentum % -49.05
52-Week Range ($) 17.24 - 47.97
Shares Outstanding (Mil) 60.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Spyre Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Spyre Therapeutics Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Spyre Therapeutics Inc Frequently Asked Questions

What is Spyre Therapeutics Inc(SYRE)'s stock price today?
The current price of SYRE is $18.03. The 52 week high of SYRE is $47.97 and 52 week low is $17.24.
When is next earnings date of Spyre Therapeutics Inc(SYRE)?
The next earnings date of Spyre Therapeutics Inc(SYRE) is 2025-05-09 Est..
Does Spyre Therapeutics Inc(SYRE) pay dividends? If so, how much?
Spyre Therapeutics Inc(SYRE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1